Literature DB >> 1200724

Staphylococcal endocarditis in drug users. Clinical and microbiologic aspects.

C U Tuazon, T A Cardella, J N Sheagren.   

Abstract

Forty patients had staphylococcal endocarditis and a history of parenteral drug abuse. Clinical and microbiologic features of their cases were evaluated. None of our patients were known to have had preexisting valvular disease. The tricuspid valve lesions and their pulmonary complications were the predominant findings. Systemic complications in the form of meningitis, glomerulonephritis, empyema, arthritis, and nosocomial Gram-negative septicemia occurred in 33% of our patients. Of interest was the high incidence of reactions to therapy especially with methicillin sodium, which occurred in 30% of patients. Correlation of phage type and group with the antibiotic sensitivities of individual staphylococci showed that group 3 and phage types 6, 42E, 54, and 75 were much more resistant to penicillin than other groups and types. The clinical outcome did not relate to phage type and group or to antibiotic sensitivity of the organism.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1200724

Source DB:  PubMed          Journal:  Arch Intern Med        ISSN: 0003-9926


  12 in total

Review 1.  Pulmonary complications of intravenous drug misuse. 2. Infective and HIV related complications.

Authors:  C R Hind
Journal:  Thorax       Date:  1990-12       Impact factor: 9.139

2.  Teichoic acids in pathogenic Staphylococcus aureus.

Authors:  J G Nagel; J N Sheagren; C U Tuazon; T A Cardella
Journal:  J Clin Microbiol       Date:  1977-09       Impact factor: 5.948

3.  New type of staphylococcal endocarditis.

Authors:  E G Smyth; E D Wright; R R Marples
Journal:  J Clin Pathol       Date:  1988-07       Impact factor: 3.411

4.  Vancomycin for Staphylococcus aureus endocarditis in intravenous drug users.

Authors:  P M Small; H F Chambers
Journal:  Antimicrob Agents Chemother       Date:  1990-06       Impact factor: 5.191

5.  Prospective evaluation of a two-week course of intravenous antibiotics in intravenous drug addicts with infective endocarditis. Grupo de Estudio de Enfermedades Infecciosas de la Provincia de Cádiz.

Authors:  M Torres-Tortosa; M de Cueto; A Vergara; A Sánchez-Porto; E Pérez-Guzmán; M González-Serrano; J Canueto
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1994-07       Impact factor: 3.267

6.  Twice-daily intramuscular ceforanide therapy of Staphylococcus aureus endocarditis in parenteral drug abusers.

Authors:  R L Greenman; S M Arcey; D A Gutterman; R M Zweig
Journal:  Antimicrob Agents Chemother       Date:  1984-01       Impact factor: 5.191

7.  Methadone: antimicrobial activity and interaction with antibiotics.

Authors:  J N Sheagren; I S Barsoum; M Y Lin
Journal:  Antimicrob Agents Chemother       Date:  1977-12       Impact factor: 5.191

8.  Candida endophthalmitis in heroin addicts.

Authors:  M Hogeweg; P T de Jong
Journal:  Doc Ophthalmol       Date:  1983-02-28       Impact factor: 2.379

9.  Antibody levels to bacterial peptidoglycan in human sera during the time course of endocarditis and bacteremic infections caused by Staphylococcus aureus.

Authors:  A R Zeiger; C U Tuazon; J N Sheagren
Journal:  Infect Immun       Date:  1981-09       Impact factor: 3.441

10.  Evaluation of ceforanide as treatment for staphylococcal and streptococcal endocarditis.

Authors:  R H Cooper; C B Savitch; W P Joseph; J Mills
Journal:  Antimicrob Agents Chemother       Date:  1981-02       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.